Lumexa Imaging Announces Third Quarter 2026 Results
Key Highlights
- ➤Revenue $272.0 million, up 5.0% year over year
- ➤Net income $7.2 million versus prior-year $3.5 million loss
- ➤Adjusted EBITDA $62.6 million, up from $59.1 million
- ➤Adjusted EPS guidance raised to $0.86-$0.90 from $0.71-$0.77
- ➤2026 revenue guidance reiterated at $1.045 billion-$1.097 billion
Expert Statements
Caitlin Zulla, Chief Executive Officer of Lumexa Imaging
“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan. We are actively opening three new de novo centers and are on pace to achieve our goal for 8–10 new center openings this year”
Caitlin Zulla, Chief Executive Officer of Lumexa Imaging
“These achievements mark progress toward our long-term growth plans, and that progress is translating into strong, durable cash generation. We enter the fourth quarter confident in our ability to deliver for patients, partners, and shareholders.”
Caitlin Zulla, Chief Executive Officer of Lumexa Imaging
“We are leading a transformation in healthcare - delivering high-quality imaging in more convenient settings, more quickly and at meaningfully lower cost through our wholly owned centers and alongside health system partners, improving clinical and financial outcomes.”
RALEIGH, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the third quarter ended September 30, 2026.
“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan. We are actively opening three new de novo centers and are on pace to achieve our goal for 8–10 new center openings this year,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “These achievements mark progress toward our long-term growth plans, and that progress is translating into strong, durable cash generation. We enter the fourth quarter confident in our ability to deliver for patients, partners, and shareholders.”
Get started
Create a free account to read the full story.